Results 31 to 40 of about 281 (94)
Evidence-Based Complementary and Alternative Medicine, Volume 2023, Issue 1, 2023., 2023 Objective. Shen Qi Wan (SQW) is the most classic prescription for the clinical therapy of chronic kidney disease in China. Nevertheless, the function of SQW in renal interstitial fibrosis (RIF) has not been clearly clarified. Our purpose was to explore the protective function of SQW on RIF. Methods. After intervention with SQW‐containing serum alone at
Hongshu Chen +4 more
wiley +1 more source
Evidence-Based Complementary and Alternative Medicine, Volume 2022, Issue 1, 2022., 2022 Introduction. IgA nephropathy (IgAN) is a common issue. In China, Abelmoschus manihot (AM) is widely used in the treatment of IgAN. However, their combined effectiveness and safety for this purpose have not yet been explored. AM is an effective medicine for treating IgAN. This meta‐analysis aimed to evaluate the effectiveness of AM for IgAN.
Qi Jia +10 more
wiley +1 more source
Phytotherapy Research, Volume 35, Issue 1, Page 198-206, January 2021., 2021 Abelmoschus manihot, also called as “Huangkui” in Chinese, is an annual flowering herb plant in the family of Malvaceae. As a traditional Chinese medicine, the ethanol extract of the flower in Abelmoschus manihot is made as Huangkui capsule and has been used for medication of the patients with kidney diseases.
Nan Li +8 more
wiley +1 more source
What was new at the 2023 American Diabetes Association meeting?
, 2023 Journal of Diabetes, Volume 15, Issue 8, Page 636-639, August 2023.
Zachary Bloomgarden
wiley +1 more source
, 2023 Introduction: As a traditional Chinese medicine, Abelmoschus manihot (L.) in the form of Huangkui (HK) capsule has been used as a medication for kidney diseases, including diabetic nephropathy (DN), in China.
Haitao Tang +23 more
core +1 more source
International Journal of Endocrinology, Volume 2020, Issue 1, 2020., 2020 Purpose. Hyperoside, a flavonoid isolated from conventional medicinal herbs, has been demonstrated to exert a significant protective effect in diabetic nephropathy. This study aimed to determine the underlying mechanisms, by which hyperoside inhibits high glucose‐(HG‐) induced proliferation in mouse renal mesangial cells. Methods.
Le Zhang +9 more
wiley +1 more source
Complementary Therapies in Medicine, 2022 Background: Bailing Capsule (BLC), Jinshuibao (JSB), Huangkui Capsule (HKC), Uremic Clearance Granule (UCG), Tripterygium glycosides (TG), Compound Xueshuantong Capsule (CXC), and Shenyan Kangfu Tablet (SYKFT) as classic Chinese patent medicines (CPMs ...
Jie Zhao +4 more
doaj +1 more source
Mechanisms of Herbal Nephroprotection in diabetes mellitus
Journal of Diabetes Research, Volume 2020, Issue 1, 2020., 2020 Diabetic nephropathy (DN) is a leading cause of kidney morbidity. Despite the multilayered complexity of the mechanisms involved in the pathogenesis of DN, the conventional treatment is limited to just a few drug classes fraught with the risk of adverse events, including the progression of renal dysfunction. Phytoceuticals offer a promising alternative
Dorin Dragoș +4 more
wiley +1 more source
, 2020 Matrix metalloproteinase-9 (MMP-9) and matrix metalloproteinase-2 (MMP-2) play important roles in the progression of renal interstitial fibrosis (RIF). There is an increasing demand to construct a novel method for the simultaneous detection of MMP-9 and ...
Ran Zhang +19 more
core +1 more source
Clinical effect of Jinhu Gushen prescription in reducing urinary protein and blood uric acid in patients with diabetic kidney disease [PDF]
精准医学杂志Objective To investigate the clinical effect of Jinhu Gushen prescription in the treatment of diabetic kidney disease (DKD). Methods A retrospective cohort study was conducted among 157 patients with DKD who were admitted to Department of Endocrinology ...
LI Yixuan, HUANG Yajing, WEI Fanxiang, LI Wenxuan, XU Lili, WANG Yangang
doaj +1 more source